Cross, N., Ernst, T., Rinke, J., Žižková, H., Cross, A., Polakova, K. M., Spiess, B., Tapper, W., White, H., Hochhaus, A. (2025). BCR::ABL1/GUSB halving times predict molecular response to asciminib at 18 months. Blood. https://doi.org/10.1182/blood-2025-5553